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Summary A group of 424 lymphomas diagnosed as centroblastic-centrocytic lymphomas at the Lymph Node
Registry in Kiel was subdivided into small (S), mixed (M) and large (L) cell groups, according to the
"working formulation" proposed in a National Cancer Institute sponsored study. Histological epidemiological
and clinical parameters were studied. It was found that in group S a follicular growth pattern was most
frequent and in group L a follicular and diffuse growth, while group M took an intermediate position. No
statistically significant differences were found in respect to epidemiological factors or overall survival.
However, in the first 6 years after the diagnosis the survival in group S was better than in group M, but
thereafter a reversal occurred. Group L appeared to have the worst survival throughout. Growth pattern and
sclerosis were found to be of limited influence on survival within the cytological groups.
Several different cytological or combined
cytological-immunological classifications of non-
Hodgkin's lymphomas are currently used
(Rappaport, 1966; Lukes, 1974; Lennert, 1978,
1981). In general, small cell and follicular
lymphomas follow a more favourable course than
their large cell and diffuse counterparts. However,
the use of different classifications often makes
individual clinical or pathologic studies difficult to
compare to each other (Nathwani, 1979; Musshoff
et al., 1981). Therefore, an international study
sponsored by the National Cancer Institute (1982)
was undertaken in order to compare six major
classifications with each other and define a
common "working formulation" (WF) for clinical
usage, based on morphologic criteria.
In the Kiel-classification (Lennert, 1978, 1981)
the centroblastic-centrocytic (CBCC) lymphomas
form a well-defined group of generally low-grade
malignant lymphomas. They are composed of small
or large cleaved and large non-cleaved follicular
centre cells, designated as centrocytes and
centroblasts, respectively. The relative contribution
of each cell type, however, varies considerably
between individual cases. Therefore, a group of 424
CBCC-lymphomas was subdivided according to the
WF into small cell (group S), mixed cell (group M)
and large cell (group L) groups. Histological,
epidemiological and clinical parameters were
compared between the 3 groups.
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Material and methods
A group of 424 patients was selected on the basis
of (a) a histological diagnosis of "CBCC
lymphoma" made at the Lymph Node Registry in
Kiel between 1953 and 1978; (b) the availability of
paraffin sections of good quality and (c) the
presence of clinical data. All histologic material,
including follow-up biopsies of 54 patients was
studied in Haematoxylin-eosin and/or Giemsa
stained sections.
On the basis of light microscopic examination of
all available material the relative contribution of
each cell type was estimated (W.M.M.). As defined
by the WF, group S consisted of cases in which
small cleaved cells predominated, group M of those
in which no clear predominance of small or large
cells could be established and group L of those with
a majority of large cleaved or noncleaved cells.
Growth pattern was designated as follicular, diffuse
or follicular and diffuse, without quantification of
each component. The presence of sclerosis was
designated but not graded.
Clinical data were collected by personal
evaluation of the patients' files (H.B.) and by
means of questionnaires returned by the patients or
their relatives (further details in preparation). The
treatment of the patients was variable reflecting the
changing trends in treatment in the 6th through 8th
decades of the century and due to the widespread
geographical distribution of the patients. The
survival periods were calculated from the date of
the histological diagnosis till the patient's death or
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the last date of information. At the end of the
study 174 patients were still alive, whose follow-up
periods ranged from 2 to 312 months (median 68
months).
All data on classification, age, sex, survival
period, life or death, site, first or follow-up biopsy
were computerized (J.K.). Most calculations,
actuarial survival curves and statistical analyses
were processed automatically (SPSS update 7-9,
1981).
Results
Cytological classification
The distribution of all studied biopsies among the
cytological groups is represented in Table I. It is
apparent that the vast majority of the initial
biopsies are classified in group S. Among the
follow-up biopsies relatively many were classified as
secondary centroblastic lymphomas.
Table 1 Distribution of initial and follow-up biopsies
among the various cytological groups.
Biopsies (n, %)
Group Ist 2nd 3rd Total
S 349 (82.7) 35 (64.8) 4 (57.1) 388 (80.0)
M 67 (15.5) 3 (5.5) 0 70 (14.4)
L 8 (1.9) 1 (1.8) 0 9 (1.9)
sCB 15 (27.8) 3 (42.8) 18 (3.7)
Total 424 (100) 54 (100) 7 (100) 485 (100)
S: small, M: mixed, L: large cell, sCB: secondary
centroblastic lymphomas.
Primary tumor site
Three hundred and eighty-one (89.9%) of the
primary biopsies were nodal, 43 (10.1%)
extranodal, including spleen (19), tonsil (18), skin
(2) and others. All of the splenic cases were
classified in group S; 12, 4 and 2 of the tonsillar
cases in groups S, M and L, respectively and one
case each of the dermal cases in groups M and L.
Sex and age ofpatients (Table II, Figure 1)
One hundred and eighty-seven patients were male,
235 female (ratio 0.78). The age of the patients
ranged from 22 to 89 years (mean 55.1 years), male
patients ranged between 22 and 89 years (mean
53.8years) and females between 24 and 82 (mean
53.8 years).
No statistical differences in sex or age
distribution were found between the various groups.
Histological parameters (Table II)
The growth pattern differed significantly (chi-
square, P<<0.01) between groups S, M and L. In
group S a follicular growth pattern predominated
and in group L a follicular and diffuse growth. In
group M both patterns were roughly equally
represented. A diffuse growth was found in only 4
cases, 3 in group S and 1 in group L. Sclerosis
occurred in 31% of the cases which were equally
distributed throughout the groups.
Survival (Table III)
Actuarial survival curves were computed to study
the influence of several parameters on survival.
None of them appeared to be of statistically
significant influence on overall survival. However,
analysis of the curves suggests a different behaviour
of the various groups in different time intervals
after the diagnosis. In respect to group L it should
be kept in mind that this group consists of only 8
patients.
Cytology (Figure 2). Comparison of the survival
curves in groups S and M reveals a better survival
in the former group in the first 6 years; the long-
term survival, however, is better in group M.
Group L seems to have the poorest short- and
long-term survival.
Table II Main histological and epidemiological characteristics.
Growth n (%) Sclerosis n (%) Sex n (%) Mean Age
Group n (%) F F+D D + - M F All M F
S 349 (82) 234 (67) 112 (32) 3 (0.6) 109 (31) 240 (69) 148 (43) 199 (57) 54.5 53.0 55.6
M 67 (16) 30 (45) 37 (55) 0 21 (31) 46 (69) 34 (50) 33 (50) 56.4 54.3 58.6
L 8 (1.8) 3 (37.5) 4 (50) 1 (12.5) 3 (37.5) 5 (62.5) 5 (62.5) 3 (37.5) 54.0 51.6 58.0
Total 424 (100) 267 (63) 153 (36) 4 (0.9) 133 (31) 291 (69) 187 (44) 235 (55) 55.1 53.8 56.1
F: follicular, D: diffuse, M: male, F: femaleWF-SUBDIVISION OF FCC LYMPHOMAS 265
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Figure 1 Age distribution. Black: total population, dots: males, circles: females.
Table III Comparison of survival in the various groups, taking different
parameters into consideration.
Parameter Group Median (months) 5-years (%) 10-years (%)
Cytology S 66 56 25
M 51 47 32
L 35 60
sCB 8 0
Growth pattern S, F 72 70 26
F+D 60 50 23
M, F 49 51 30
F+D 40 49 35
L, F 19 32 -
F+D 61
Sclerosis S,- 68 57 23
+ 64 53 28
M,- 40 40 20
+ 160 66 60
L, - 28 40 -
+ 68
Growth pattern (Figure 3a, b,c). Both in groups S
and M a follicular growth pattern gives a better
initial survival than a follicular and diffuse growth,
but after 10 and 5 years, respectively, a reversal
occurs. In group L a follicular and diffuse growth
seems to give a better survival throughout.
Sclerosis (Figure 4a, b,c). In group S sclerosis has
no apparent influence on survival. Both in groups
M and L, however, the presence of sclerosis seems
to give a better survival.
Transition into a high-grade malignant lymphoma
In 18 cases (4.2%) a secondary centroblastic (sCB)
lymphoma was diagnosed in a follow-up biopsy, i.e.
in 14 cases of group S (4.0%) and in 4 cases of
group M (6.0%). The mean time lapse between the
initial CBCC-biopsy and the sCB-biopsy was 52.2100
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Figure 3 Actuarial survival in CBCC-lymphomas subdivided by growth pattern
(a) Group S (F, n=234; F+D, n= 113)
(b) Group M (F, n=30; F+D, n=37)
(c) Group L (F, n=3; F+D, n=5)
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Figure 4 Actuarial survival in CBCC-lymphomas subdivided according to presence or
absence of sclerosis
(a) Group S (+, n= 109; -, n=240)
(b) Group M (+, n=21; -, n=46)
(c) Group L (+, n=3; -, n=5)
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months (1-132 months) in group S and 25.0 months
(9-72) in group M. No statistical differences were
found between the two groups.
Discussion
The CBCC-lymphomas of the Kiel-classification
(Lennert, 1978, 1981) form a rather well defined
group, although the relative contribution of each
follicular centre cell type may vary considerably. In
order to study the relevance of the cellular
composition a large group of such lymphomas was
subdivided into small (group S), mixed (group M)
and large (group L) cell groups, according to the
criteria of the WF which was proposed on
instigation of the National Cancer Institute. The
relative frequency of group S (83%) appeared
higher than that in the corresponding group B of
the WF-study (66%) and that of group M (16%)
lower than that in the corresponding group C
(23%). This may be due to the wide range between
"follicles composed predominantly of small cells"
and those with "no clear predominance of one cell
type (small or large) over the other" as defined for
groups B and C, respectively (WF). It implies that
the present group S included relatively many cases
with a relatively high number of centroblasts, but
with a clear predominance of centrocytes. The low
frequency of cases in group L (1.9%) as compared
to group D (11.2%) in the WF-study may be
explained by the exclusion of predominantly
centroblastic cases, which are classified as
centroblastic in the Kiel-classification. Moreover,
the incidence of large cell lymphomas in the U.S.A.
may be higher than that in Europe.
The age and sex distribution of patients in the
present series are comparable to several other
studies (Jones et al., 1973; Kim & Dorfman, 1974;
Patchefsky et al., 1974; Qazi et al., 1976; Elias,
1979; Lennert, 1978, 1981; Musshoff, 1981;
Molenaar et al., 1983). No statistically significant
differences were found in the cytological groups.
The growth pattern differed significantly between
the various groups, such that an entirely follicular
growth was most frequent in group S and a
follicular and diffuse growth in group L, while
group M took an intermediate position. These, as
well as earlier findings (Rappaport, 1966; Jones et
al., 1973; Kim & Dorfman, 1974; Lukes & Collins,
1974; Patchefsky, 1974; Qazi et al., 1976; Warnke et
al., 1977; Stein et al., 1979; Damber et al., 1982;
Molenaar et al., 1983) suggest that a relatively high
proportion of large cells correlates with a diffuse
growth.
Transition into a sCB-lymphoma occurred in 4%
of the cases without significant differences in
incidence or time lapse between the groups. This
figure is low as compared to other reports (Qazi et
al., 1976; Risdall et al., 1979; Cullen et al., 1979;
Lennert, 1981; Hubbard et al., 1982), 3 of which,
however, (Qazi et al., 1976; Risdall et al., 1979;
Hubbard et al., 1982) were based on autopsy
findings. Moreover, in the present study only cases
that were histologically proven in the Lymph Node
Registry in Kiel were taken into consideration,
although in several more patients a change into a
high-grade malignancy was clinically suspected
and/or histologically proven elsewhere.
Survival. In studying the survival in the present
series the long follow-up must be emphasized,
giving statistically reliable information. It implies
also that most of the patients received initial
therapy before modern treatment regimens were
developed, resulting in a relatively "natural" history
of the disease.
No statistically significant differences were found
in respect to cytology, growth pattern or sclerosis.
As in the Kiel-classification (Lennert, 1978), slight
differences were observed, however, in that the
presence of many large centrocytes (group L) or of
relatively many centroblasts (group M) gives a
poorer median survival. The long-term prognosis in
group M, however, appeared better than that in
group S, which has also been observed by others
(Hermann et al., 1982). Similar to Bennett's
observations (quoted by Lennert, 1978) sclerosis
gave a better survival in groups M and L. The
prognostic significance of the growth pattern has
been debated for a long time (Patchefsky et al.,
1974; Warnke et al., 1977; Damber et al., 1982;
WF-study, 1982; Molenaar et al., 1983). In view of
the present and many earlier findings (Jones et al.,
1973; Lukes & Collins, 1974; Patchefsky et al.,
1974; Warnke et al., 1977; Stein et al., 1979;
Damber et al., 1982; Alavaikko & Aine, 1982;
Molenaar et al., 1983) growth pattern and
cytological composition of lymphomas seem to be
closely interrelated. In the present cytologically
rather homogenous groups S and M, only a slightly
better initial survival in entirely follicular cases was
found as compared to follicular and diffuse cases.
These results contrast with those of Damber et al.
(1982), who found within one cytological group a
clear influence of growth pattern on survival. It
may be assumed, however, that their "small cleaved
cell group" includes both centrocytic and
centrocytic-centroblastic lymphomas of the Kiel-
classification. The former reportedly (Lennert, 1978,
1981) have a predominantly diffuse growth and the
latter a predominantly follicular growth. Moreover,
the former has a poorer prognosis than the latter.
Conclusions. Putting all data together it may be
concluded that the further cytological subdivision
of CBCC lymphomas did not add clinically relevant
information in the present series of patients that268 W.M. MOLENAAR et al.
were mostly treated before modern therapy had
been developed. On the other hand, a clear
difference in growth pattern was observed as well
as differences in survival pattern, which may reflect
intrinsic differences in biological potentialities, not
expressed in the "natural" history. It may be
speculated, however, that such differences gain in
relevance with the advancement of modern
multimodality treatment and may give rise to a
different therapeutic response (Stein et al., 1979;
Cabanillas et al., 1979; Mann et al., 1979; Hubbard
et al., 1982; v.d. Berg et al., 1983). This is especially
important since it has been shown that an initial
complete response gives a far better prognosis than
a partial or minimal response (Cabanillas et al.,
1979; Hermann et al., 1982).
The authors wish to thank Prof. K. Lennert for the use of
his extensive material and his helpful comments
throughout the study. They are also thankful to Mrs. L.
Kiencke for her intensive collaboration with the filing of
the patients' data, to Mr. H. Wierenga for preparing the
photographs, to Mr. J. Scheffers for his drawings and to
Mrs. A.O. Boer for typing the manuscript.
References
ALAVAIKKO, M. & AINE, R. (1982). The Lukes and
Collins classification of non-Hodgkin's lymphomas. I.
A histological reappraisal of 301 cases. Acta Pathol.
Microbiol. Immunol. (Scand. Sect. A), 90, 241.
CABANILLAS, F., SMITH, T., BODEY, G.P., GUTTERMAN,
J.U. & FREIREICH, E.J. (1979). Nodular malignant
lymphomas - factors affecting complete response rate
and survival. Cancer, 44, 1983.
CULLEN, M.H., LISTER, T.A., BREARLEY, R.L., SHAND,
W.S., & STANSFELD, A.G. (1979). Histological
transformation of non-Hodgkin's lymphoma. A
prospective study. Cancer, 44, 645.
DAMBER, L., LENNER, P. & LUNDGREN, E. (1982). The
impact of growth pattern on survival in non-
Hodgkin's lymphomas classified according to Lukes
and Collins. Pathol. Res. Pract., 174, 42.
ELIAS, L. (1979). Differences in age and sex distributions
among patients with non-Hodgkin's lymphoma.
Cancer, 43, 2540.
HERRMANN, R., BARCOS, M., STUTZMAN, L. & 4 others.
(1982). The influence of histologic type on the
incidence and duration of response in non-Hodgkin's
lymphoma. Cancer, 49, 314.
HUBBARD, S.M., CHABNER, B.A., DE VITA, D.T. & 7
others. (1982). Histologic progression in non-
Hodgkin's lymphoma. Blood, 59, 258.
JONES, S.E., FUKS, Z., BULL, M. & 5 others. (1973). Non-
Hodgkin's lymphomas. IV. Clinico-pathologic
correlation in 405 cases. Cancer, 31, 806.
KIM, H. & DORFMAN, R.F. (1974). Morphological atudies
of 84 untreated patients subjected to laparotomy for
the staging of non-Hodgkin's lymphomas. Cancer, 33,
657.
LENNERT, K. (1978). Malignant lymphomas other than
Hodgkin's disease. In: Histology, Cytology,
Ultrastructure, Immunology. Springer Verlag, Berlin-
Heidelberg-New York. p. 00
LENNERT, K. (1981). Histopathology of non-Hodgkin's
Lymphomas. Springer Verlag, Berlin-Heidelberg-New
York. p. 00.
LUKES, R.M. & COLLINS, R.D. (1974). Immunologic
characterization of human malignant lymphomas.
Cancer, 34, 1488.
MANN, R.B., JAFFE, E.S. & BERARD, C.W. (1979).
Malignant lymphomas - a conceptual understanding
ofmorphologic diversity. Am. J. Pathol., 94, 105.
MOLENAAR, W.M., VAN DER BERG, H.M., HALIE, M.R. &
POPPEMA, S. (1983). The heterogeneity of follicular
center cell lymphomas. I. Cytohistological,
immunological and enzymehistochemical aspects.
Cancer, 52, 2269.
MUSSHOFF, K., V. STOTZINGEN, W., SCHMIDT-
VOLLMER, H. & UMBACH, H. (1981). Investigation
results of a comparison made between the Kiel and
Rappaport classifications of the non-Hodgkin's
lymphomas, together with clinical data. J. Cancer Res.
Clin. Oncol., 100, 167.
NATHWANI, B.N. (1979). A critical analysis of the
classification of non-Hodgkin's lymphomas. Cancer,
44, 347.
NATIONAL CANCER INSTITUTE. (1982). Sponsored study
of classifications of non-Hodgkin's lymphomas.
Summary of description of a working formulation for
clinical usage. Cancer, 49, 2112.
PATCHEFSKY, A.S., BRODOVSKY, H.S., MENDUKE, H. &
4 others. (1974). Non-Hodgkin's lymphomas: a
clinicopathologic study of 293 cases. Cancer, 34, 1173.
QAZI, R., AISENBERG, A.C. & LONG, J.D. (1976). The
natural history of nodular lymphoma. Cancer, 37,
1923.
RAPPAPORT, H. (1966). Atlas of Tumor Pathology.
Tumors of the Hematopoietic System. Washington,
DC, Armed Forces Inst. Pathol. p. 00.
RISDALL, R., HAPPE, R.T. & WARNKE, R. (1979). Non-
Hodgkin's lymphoma: a study of the evolution of the
disease based upon 92 autopsied cases. Cancer 44, 529.
SPSS UPDATE 7-9. (1981). New Procedures and Facilities
for Releases 7-9. (Eds. Hull & Nie) McGraw-Hill
Book Company, Chicago.
STEIN, R.S., COUSAR, J., FLEXNER, J.M. & 4 others.
(1979). Malignant lymphomas of follicular center cell
origin in man. III. Prognostic features. Cancer, 44,
2236.
VAN DEN BERG, H.M., MOLENAAR, W.M., POPPEMA, S.
& HALIE, M.R. (1983). The heterogeneity of nodular
follicle center cell tumors. II. Clinical follow-up of 30
patients. Cancer 52, 2264.
WARNKE, R.A., KIM, H., FUKS, Z. & DORMAN, R.F.
(1977). The co-existence of nodular and diffuse
patterns in nodular non-Hodgkin's lymphomas.
Cancer, 40, 1229.